Teva reveals CEO paid NIS 14.7m in total compensation last year
Executive pay at Teva was the subject of a class action suit in which it was claimed the corporation violated securities laws requiring them to disclose the pay of each of its five best paid employees.
The compensation package of Jeremy Levin, CEO of Teva Pharmaceutical Industries, amounted to NIS 14.7 million in 2012, the company said on Wednesday, revealing such information for the first time since 2000.
register with haaretz
Like us on Facebook and get articles directly in your news feed